Status epilepticus is a medical emergency that requires rapid and vigorous treatment to prevent neuronal damage and systemic complications. Refractory status epilepticus refers to sustained seizures that do not respond to initial drug therapy and persist longer than 60 minutes. Admission of such patients to an intensive care unit setting and meticulous hemodynamic monitoring is mandatory. We describe a case of Lafora body disease, an autosomal recessive form of progressive myoclonus epilepsy characterized by seizures and cumulative neurological deterioration.
INTRODUCTION
Status epilepticus (SE) is a situation with high morbidity and mortality, causing transient or consistent brain damage, lasting for half an hour or more resistance [ 1 ] . SE can be caused by a stroke, hypoxic injury, toxic, metabolic, infectious, traumatic, tumoral and genetic reason, or idiopathic [ 2 ] . Patients in status epilepticus present a clinical emergency. On one hand, the clinician's objective is to control the seizures quickly and to prevent recurrences; on the other hand, to determine true etiologic factor by laboratory and neuroimaging and EEG studies [ 2 , 3 , 4 , 5 ] .
Arterial blood gas analysis may reveal a metabolic acidosis [ 6 , 7 ] . Cardiac and other hemodynamic monitoring should be established urgently. The purpose of this report is to review management of refractory status epilepticus in a patient with Lafora disease, who had repeated attacks of severe myoclonus, tonic-clonic convulsions, and refractory status epilepticus.
CASE REPORT
A 19 years old male patient had his first convulsion at 9 years old. His seizures repeated with a rapid onset three years later and carbamazepin and valproat was begun. However his seizures continued once a month for the next two years, clonezepam and vigabatrin was added to the treatment. Progressive worsening in memory, increased frequency in seizures, myoclonus and ataxia were followed until he was sixteen. Lafora body disease was diagnosed on skin biopsy at that time. Seizure frequency had increased as 2-3 times in a week for the next three years. The patient admitted to emergency service with status epilepticus was accepted unconsciously in our intensive care unit. Valproat, clonozepam and phenytoin were administered in the intensive care unit. Unfortunately this regimen failed to stop generalized tonic-clonic seizures so that midazolam and thiopental infusions were added to the therapy. But the seizures in his face and eyelids continued. The respiration was maintained with mechanical ventilation, and hemodynamic and nutritional supportive treatments were performed. Also, electrolyte and metabolic disturbances were eliminated and managed as the patients' need. Thiopental infusion therapy could not be ceased because when infusion rate decreased generalized seizures repeated. Against all these therapeutic interventions the patient was lost with the complication of sepsis at the 68th day.
DISCUSSION
We have reported long-term clinical follow-up of a case with Lafora disease, who had repeated attacks of severe myoclonus, tonic-clonic convulsions, ataxia, dementia, and refractory status epilepticus. ]. In our patient, the diagnosis of Lafora disease had been proved by skin biopsy at 16 years old.
Refractory status epilepticus refers to sustained seizures that do not respond to initial drug therapy and persist longer than 60 minutes. Refractory status epilepticus is a major medical and neurological emergency that requires immediate treatment to avoid significant morbidity and mortality. Treatment of Lafora disease is essentially supportive because no definitive therapy available. The myoclonic jerks are difficult to control, but a combination of valproic acid and a benzodiazepine is effective in controlling the generalized seizure. Group of phenytoin and barbiturates may require for the refractory status epilepticus [ 22 ] . Initially our patient was treated with carbamazepin and valproat, later clonezepam and vigabatrin, followed by midazolam and thiopental infusion in our intensive care unit. Also respiratory, hemodynamic and nutritional treatments were administered. It was reported that these patients dies 2-10 years after onset of the disease [ 15 ] . Our patient had died in 9 th year of the onset of the disease.
CONCLUSIONS
As a conclusion, these kinds of refractory status epilepticus disorders must be treated rapidly and aggressively. Management of seizures, rhabdomyolysis, oxygenation, hemodynamic stability, electrolytes and metabolic disturbances, and nutritional support should be carried in an intensive care unit. 
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